Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease is a research paper published in Gastroenterology (2020). On theSindex it has a DataRank of 0.644. It has been cited 72 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.644
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Diabetes and Digestive and Kidney Diseases
Grant: P01 DK046763
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: U01 DK062413
National Institutes of Health
Grant: 5P01DK046763-22
IBD: Genetic and Immunopathologic Mechanisms
National Institutes of Health
Grant: 2U01DK062413-16
Genetic and genomic approaches to better understand the clinical heterogeneity in inflammatory bowel diseases
Janssen Pharmaceuticals
Leona M. and Harry B. Helmsley Charitable Trust
Takeda Pharmaceuticals U.S.A.
Pfizer
Gilead Sciences
Boehringer Ingelheim
National Institutes of Health
FWCI
1.07
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway
Additional file 1 of ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway